PTPA and cancer: Several neurodegenerative diseases and cancers are connected with lower PP2A activity and PP2A activators may manifest great potential as drug therapy.173–175 After ischemia/reperfusion, increased PP2A and decreased AMPKα phosphorylation at T172 has been observed, attributing to acute kidney injury.